Other protein kinase inhibitors
Nintedanib
The FDA lists this product in 8 strengths and forms.
Composition
- Active ingredients
- NINTEDANIB 100MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- NINTEDANIB 100MG · CapsuleThis page
- NINTEDANIB 25MG · CapsuleANDA218472-003 · Tentative approval
- NINTEDANIB 100MG · CapsuleANDA219708-002 · Tentative approval
- NINTEDANIB 100MG · CapsuleANDA219371-002 · Tentative approval
- NINTEDANIB 25MG · CapsuleANDA219371-003 · Tentative approval
- NINTEDANIB EQ 150MG BASE · CapsuleANDA212732-002 · Tentative approval
- NINTEDANIB EQ 100MG BASE · CapsuleANDA212732-001 · Tentative approval
- NINTEDANIB EQ 150MG BASE · CapsuleANDA215123-002 · Tentative approval
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218472.